Page 763 - Coronavirus Vaccine

Now 'real hope' to end coronavirus with vaccines: WHO chief Ghebreyesus

"There is now real hope that vaccines, in combination with other tried and tested public health measures, will help to end the pandemic," said WHO Director-General Tedros Adhanom Ghebreyesus

How Bill Gates is working with WHO, drugmakers to defeat the coronavirus

The billionaire is working with the W.H.O., drugmakers and nonprofits to defeat the coronavirus everywhere, including in the world's poorest nations. Can they do it?

PM Modi holds virtual meet with states over coronavirus situation

Prime Minister Narendra Modi on Tuesday interacted via video conferencing with chief ministers of states that are witnessing a surge in coronavirus cases to review the COVID-19 situation

India coronavirus update: Covid-19 caseload climbs to 9.17 million

India saw 37,975 new coronavirus infections being reported in a day taking the country's Covid-19 caseload to 9.17 million, while the recoveries crossed 860,000

India faces cold chain logistics challenge for Covid-19 vaccination

The nation with the world's second-highest infections plans to use the existing cold chain network in place for its Universal Immunization Program

Allahabad HC asks Centre to arrange virtual meet with ICMR on Covid vaccine

The court further directed SSP Prayagraj Sarvshresth Tripathi to apprise it with the progress in deployment of police to enforce the mandatory use of face masks in public places in the city

Sensex, Nifty march higher on Covid-19 vaccine progress news; ONGC rises 6%

After touching a record intra-day high of 44,271.15, Sensex ended 194.90 points or 0.44 per cent higher at 44,077.15

Euro zone business activity shrinks but Covid vaccine hopes boost optimism

The bloc's economy is on track for its first double-dip recession in nearly a decade as a second wave of the coronavirus sweeps across Europe, a Reuters poll suggested last week

PM Narendra Modi to review coronavirus situation with CMs on Tuesday

Amid the rising cases of coronavirus, Prime Minister Narendra Modi is scheduled to review the situation on Tuesday with the Chief Ministers, sources said

Gold falls to 4-month low as stocks jump on strong US data, vaccine boost

Gold's break below $1,850 triggered a wave of sell stops, said Phillip Streible, chief market strategist at Blue Line Futures in Chicago

How a dosing error turned into lucky punch for AstraZeneca and Oxford

"The reason we had the half-dose is serendipity," Mene Pangalos, the head of AstraZeneca's non-oncology research and development, told Reuters

WHO says $4.3 billion urgently needed for Covid-19 vaccine sharing scheme

It has so far raised $5 billion, including more than 500 million euros ($600 million) from Germany

Oxford-AstraZeneca vaccine shows positive results, up to 90% efficacy

Data from global trials to be submitted to the Indian regulator by the end of December

Serum Institute, Bharat Biotech gear up to export Covid-19 vaccine shots

Serum, Bharat Biotech in talks with countries, agencies to supply vaccines

Serum Institute to focus on supplying Oxford Covid vaccine to India first

Poonawalla said the company will be able to produce 400 million doses of AstraZeneca's vaccine by July 2021 and scale up further from there

Can't wait for majority to be vaccinated, need to open borders now: IATA DG

According to IATA's assessment, COVID-19 vaccine won't be widely available till the second half of 2021

Oil prices rise as traders anticipate vaccine trials may spur demand

Brent crude rose 58 cents to $45.54 a barrel by 1435 GMT while U.S. West Texas Intermediate crude gained 35 cents to $42.77 a barrel. Both benchmarks jumped 5% last week.

Wall Street opens higher as Covid-19 vaccine progress fuels recovery hopes

The Dow Jones Industrial Average rose 69.34 points, or 0.24%, at the open to 29,332.82

Bill Gates, coronavirus and the initiative to vaccinate the world

If the initiative, aided by Mr. Gates's fortune and focus, manages to help protect the world's poor from a virus it will affirm the strategies he has promoted in his philanthropic work

Delighted at AstraZeneca vaccine's effectiveness: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Monday expressed happiness at pharma major AstraZeneca's announcement that its COVID-19 vaccine candidate has been found to be 70 per cent effective on average. AstraZeneca said one dosing regimen showed vaccine efficacy of 90 per cent when the vaccine was given as a half-dose followed by a full dose at least one month apart, while another dosing regimen showed 62 per cent efficacy when given as two full doses at least one month apart. "The combined analysis from both dosing regimens resulted in an average efficacy of 70 per cent," it added. In a tweet, Poonawalla said, "I am delighted to hear that, Covishield, a low-cost, logistically manageable & soon to be widely available, #COVID19 vaccine, will offer protection up to 90% in one type of dosage regime and 62% in the other dosage regime...". SII is currently conducting clinical trials of Oxford University-AstraZeneca's COVID-19 vaccine candidate in India. AstraZeneca also ...